HEADER NUCLEAR PROTEIN 27-OCT-06 2J8P TITLE NMR STRUCTURE OF C-TERMINAL DOMAIN OF HUMAN CSTF-64 COMPND MOL_ID: 1; COMPND 2 MOLECULE: CLEAVAGE STIMULATION FACTOR 64 KDA SUBUNIT; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: RESIDUES 531-577; COMPND 5 SYNONYM: CSTF 64 KDA SUBUNIT, CF-1 64 KDA SUBUNITCSTF-64, CSTF-64; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 8 EXPRESSION_SYSTEM_PLASMID: PET28 KEYWDS CLEAVAGE/POLYADENYLATION, ALTERNATIVE SPLICING RNA15, PCF11, CSTF-64, KEYWDS 2 RNA-BINDING, NUCLEAR PROTEIN, MRNA PROCESSING, PHOSPHORYLATION EXPDTA SOLUTION NMR NUMMDL 30 AUTHOR X.QU,J.M.PEREZ-CANADILLAS,S.AGRAWAL,J.DE BAECKE,H.CHENG,G.VARANI, AUTHOR 2 C.MOORE REVDAT 4 15-MAY-24 2J8P 1 REMARK REVDAT 3 24-FEB-09 2J8P 1 VERSN REVDAT 2 23-JAN-07 2J8P 1 JRNL REVDAT 1 06-NOV-06 2J8P 0 JRNL AUTH X.QU,J.M.PEREZ-CANADILLAS,S.AGRAWAL,J.DE BAECKE,H.CHENG, JRNL AUTH 2 G.VARANI,C.MOORE JRNL TITL THE C-TERMINAL DOMAINS OF VERTEBRATE CSTF-64 AND ITS YEAST JRNL TITL 2 ORTHOLOGUE RNA15 FORM A NEW STRUCTURE CRITICAL FOR MRNA JRNL TITL 3 3'-END PROCESSING. JRNL REF J.BIOL.CHEM. V. 282 2101 2007 JRNL REFN ISSN 0021-9258 JRNL PMID 17116658 JRNL DOI 10.1074/JBC.M609981200 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CYANA REMARK 3 AUTHORS : P.GUNTERT,C.MUMENTHALER,K.WUTHRICH REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2J8P COMPLIES WITH FORMAT V. 3.15, 01-DEC-08 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 27-OCT-06. REMARK 100 THE DEPOSITION ID IS D_1290030352. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 298.0 REMARK 210 PH : 6.0 REMARK 210 IONIC STRENGTH : 25 MM POTASSIUM PHOSPHATE REMARK 210 PRESSURE : 1.0 ATM REMARK 210 SAMPLE CONTENTS : 10% D2O/90% H2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 3D HNCA; 3D HN(CO)CA; 3D REMARK 210 CBCA(CO)NH; 3D HCCH-COSY; 3D 13C- REMARK 210 NOESY-HSQC; 3D 15N- NOESY-HSQC; REMARK 210 2D 15N-HSQC; 2D 13C-HSQC; 2D REMARK 210 NOESY; 2D TOCSY REMARK 210 SPECTROMETER FIELD STRENGTH : 600 MHZ REMARK 210 SPECTROMETER MODEL : DMX REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : ANSIG, TALOS, CYANA REMARK 210 METHOD USED : TORSION ANGLE DYNAMICS REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 35 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 30 REMARK 210 CONFORMERS, SELECTION CRITERIA : STRUCTURES HAVING NO DISTANCE REMARK 210 RESTRAINT VIOLATION LARGER THAN REMARK 210 0.2 A OR NO VIOLATION OF REMARK 210 DIHEDRAL ANGLE CONSTRAINTS REMARK 210 LARGER THAN 5 DEGREES REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NONE REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 MET A 530 111.77 -37.68 REMARK 500 1 THR A 531 164.52 -41.70 REMARK 500 1 LEU A 545 -90.26 -53.56 REMARK 500 1 LEU A 547 37.02 91.87 REMARK 500 1 THR A 548 116.63 -162.89 REMARK 500 1 LYS A 572 99.28 59.80 REMARK 500 1 SER A 573 -57.26 -165.35 REMARK 500 1 THR A 574 104.85 54.29 REMARK 500 2 MET A 530 118.11 -37.68 REMARK 500 2 THR A 531 167.54 -43.67 REMARK 500 2 LEU A 545 -93.75 -55.55 REMARK 500 2 LEU A 547 31.03 93.24 REMARK 500 2 LYS A 572 67.85 67.96 REMARK 500 2 THR A 574 81.65 46.99 REMARK 500 3 MET A 530 122.24 -37.74 REMARK 500 3 THR A 531 169.16 -44.35 REMARK 500 3 LEU A 545 -100.51 -71.28 REMARK 500 3 LEU A 547 61.82 67.92 REMARK 500 3 THR A 548 -48.96 -136.92 REMARK 500 3 ALA A 549 -20.68 86.44 REMARK 500 4 MET A 530 111.99 -37.18 REMARK 500 4 THR A 531 167.41 -43.49 REMARK 500 4 LEU A 545 -101.42 -73.12 REMARK 500 4 LEU A 547 105.39 76.36 REMARK 500 4 THR A 548 -47.68 -163.06 REMARK 500 4 ALA A 549 -45.13 83.96 REMARK 500 4 LYS A 572 85.07 52.90 REMARK 500 5 MET A 530 111.77 -37.64 REMARK 500 5 THR A 531 164.54 -41.90 REMARK 500 5 LEU A 545 -87.32 -53.17 REMARK 500 5 LEU A 547 42.56 88.45 REMARK 500 5 THR A 548 -48.81 -147.07 REMARK 500 5 ALA A 549 -33.24 88.56 REMARK 500 5 LYS A 572 174.04 61.11 REMARK 500 5 THR A 574 89.90 66.07 REMARK 500 6 MET A 530 121.64 -38.88 REMARK 500 6 THR A 531 169.27 -44.50 REMARK 500 6 LEU A 545 -101.95 -73.83 REMARK 500 6 LEU A 547 92.92 72.39 REMARK 500 6 THR A 548 -47.61 -157.01 REMARK 500 6 ALA A 549 -45.39 83.68 REMARK 500 6 SER A 573 -77.87 63.67 REMARK 500 6 THR A 574 -77.53 63.53 REMARK 500 7 THR A 531 -173.71 63.07 REMARK 500 7 LEU A 545 -96.11 -52.98 REMARK 500 7 LEU A 547 33.88 90.92 REMARK 500 7 THR A 548 -48.87 -130.35 REMARK 500 7 ALA A 549 -12.54 85.19 REMARK 500 7 LYS A 572 175.37 60.93 REMARK 500 8 MET A 530 111.73 -37.96 REMARK 500 REMARK 500 THIS ENTRY HAS 204 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 650 REMARK 650 HELIX REMARK 650 DETERMINATION METHOD: AUTHOR PROVIDED. REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1P1T RELATED DB: PDB REMARK 900 NMR STRUCTURE OF THE N-TERMINAL RRM DOMAIN OF CLEAVAGESTIMULATION REMARK 900 FACTOR 64 KDA SUBUNIT REMARK 999 REMARK 999 SEQUENCE REMARK 999 SESIDUES 529 AND 530 ARE REMAINS OF THE FUSION TAG REMARK 999 AFTER PROTEASE CLEAVAGE. DBREF 2J8P A 529 530 PDB 2J8P 2J8P 529 530 DBREF 2J8P A 531 577 UNP P33240 CSTF2_HUMAN 531 577 SEQRES 1 A 49 HIS MET THR PRO GLN ASP HIS GLU LYS ALA ALA LEU ILE SEQRES 2 A 49 MET GLN VAL LEU GLN LEU THR ALA ASP GLN ILE ALA MET SEQRES 3 A 49 LEU PRO PRO GLU GLN ARG GLN SER ILE LEU ILE LEU LYS SEQRES 4 A 49 GLU GLN ILE GLN LYS SER THR GLY ALA PRO HELIX 1 1 THR A 531 VAL A 544 1 14 HELIX 2 2 ALA A 549 LEU A 555 1 7 HELIX 3 3 PRO A 557 SER A 573 1 17 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1 ENDMDL MODEL 2 ENDMDL MODEL 3 ENDMDL MODEL 4 ENDMDL MODEL 5 ENDMDL MODEL 6 ENDMDL MODEL 7 ENDMDL MODEL 8 ENDMDL MODEL 9 ENDMDL MODEL 10 ENDMDL MODEL 11 ENDMDL MODEL 12 ENDMDL MODEL 13 ENDMDL MODEL 14 ENDMDL MODEL 15 ENDMDL MODEL 16 ENDMDL MODEL 17 ENDMDL MODEL 18 ENDMDL MODEL 19 ENDMDL MODEL 20 ENDMDL MODEL 21 ENDMDL MODEL 22 ENDMDL MODEL 23 ENDMDL MODEL 24 ENDMDL MODEL 25 ENDMDL MODEL 26 ENDMDL MODEL 27 ENDMDL MODEL 28 ENDMDL MODEL 29 ENDMDL MODEL 30 ENDMDL MASTER 161 0 0 3 0 0 0 6 382 1 0 4 END